IDO-1 heme-binding inhibitors (Merck Research Laboratories)

N/A

Report date: 2025/03/20 15:35:32
NME

Base Information

Drug NameIDO-1 heme-binding inhibitors (Merck Research Laboratories)
Drug Alias NameIDO-1 checkpoint inhibitor (Merck Research Laboratories)IDO checkpoint inhibitor (Merck Research Laboratories)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIndoleamine 2,3-dioxygenase inhibitors
TargetsIndoleamine 2,3-dioxygenase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesMerck & Co Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A